Renub

    United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Jan 2023
    Pages: 200

    United States Diabetes Market Outlook

    United States Diabetes Market is expected to reach US$ 28.27 Billion by 2028, according to Renub Research. In the United States, Diabetes is the 7th leading cause of death. Diabetes is a persistent disease that happens either when the pancreas has not produced enough insulin or when the body cannot effectively and efficiently uses its insulin. In the United States, the case of diabetes has risen dramatically during the last two decades, a fact driven by the increased prevalence of obesity and lifestyle changes. Diabetes ranks among the fast-growing chronic diseases in the United States. About 1.75 Million U.S. citizens are diagnosed with diabetes every year. Diabetes and pre-diabetes are leading public health concerns across the United States. About 37.3 Million Americans have diabetes, according to the CDC


    united-states-diabetes-market


    United States Diabetes Population is expected to grow with a CAGR of 3.26% from 2022 to 2028

    According to CDC, 11.3% of the U.S. population has diabetes. There are mainly two types of diabetes: type 1 and type 2. A lack of insulin production characterizes type 1 diabetes, and Type 2 diabetes is caused by the body’s ineffective use of insulin. Type 2 is typically progressive and develops in people over age 45, but there are more and more children, teenagers, and young adults who are also developing diabetes.

    It often results from excess physical inactivity and body weight. Higher than 1 in 10 adults in the United States live with type 1 or 2 diabetes. Type 2 diabetes accounts for approx 90% to 95% of all diagnosed cases of diabetes; type 1 diabetes accounts for about 5-10%. Approx. 283,000 Americans under age 20 are estimated to have been diagnosed with diabetes, nearly 0.35% of that population, according to American Diabetes Association.

    Although, over time, diabetes can damage the heart, blood vessels, eyes, kidneys, and nerves and increase the risk of heart disease and stroke. Such damage can result in reduced blood and nerve damage. Type 2 diabetes is a significant public health problem in the USA, affecting over 12% of American adults and imposing considerable health and economic burden on individuals and society. In the United States, 96 million adults, more than 1 in 3, have pre-diabetes. 


    Growing Number of Diabetic Patients in the United States will create more demand for Insulin Market

    Based on devices, United State Diabetes Market is classified into four types:  Glucose Monitoring (CGM), Self-Monitoring Blood Glucose (SMBG), Insulin Pen, and Insulin Pump. SMBG Capturing the maximum share during the forecast period due to monitoring blood glucose (SMBG) can be valuable in managing diabetes mellitus. Patients with diabetes often measure their blood glucose to detect hypoglycemia and adjust insulin doses as needed.

    The primary growth factors include the rising diabetic population, increasing awareness among the diabetes population, increasing spending on healthcare, active reimbursement policies, and technological advancement aimed at minimal and non-invasive testing methods, which significantly boost the market.

    Besides, CGM and Insulin Pens will also dominate the market revenue of the United States during the upcoming year. CGM device is a tool that measures patients glucose levels 24 hours a day.  However, Insulin pens offer the advantage of ease of administration, especially for patients with visual and dexterity issues, accuracy when administering small doses, convenience, and reduced pain. Today, about 59% of patients with diabetes use insulin pens in the U.S. 


    United States Diabetes Market was US$ 23.32 Billion in 2022

    Most of the cost of diabetes care in the U.S, is provided by government insurance (including Medicare, Medicaid, and the military). The increasing diabetes prevalence has led the Government of the U.S. to launch diabetes prevention programs, raise awareness about its symptoms and encourage healthier lifestyle behavior among the citizens. However, technological developments in diabetes devices, such as the introduction of a high-end insulin pump and pens, propel the demand for these products, leading manufacturers to focus on technological innovations and developing advanced products which boost the market.

    The U.S. Diabetes Prevention Program (DPP) clinical sequent translational studies have demonstrated that intensive lifestyle interventions focused on achieving 7% weight loss and at least 150 min per week of moderate physical activity can cut the risk of developing diabetes in half. Such interventions also improve health-related quality of life and enable some patients to reduce the need for medication.


    Key Companies Analysis

    The United States diabetes market is moderately fragmented, with few significant and generic players. The major players are B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (B.D.), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care.

    • In March 2022, Dexcom released G7 first in the U.K. and will expand the launch across Europe throughout 2022. Meanwhile, the CGM system is currently under review by the Food and Drug Administration for an eventual U.S. release.
    • In June 2022, continuous glucose monitors (CGM) were adopted among people with type 2 diabetes (T2D). However, up to 70% of CGM use is for type 1 diabetes (T1D); only 3-4% of the U.S. T2D population use CGM despite established benefits as per One Drop.


    Renub Research report titled “United States Diabetes Market & Volume Forecast by SMBG (Test Strips Market and Forecast, Lancet Market and Forecast, Meter Market and Forecast, Blood Glucose (SMBG) Users and Blood Glucose Devices Reimbursement), CGM (Glucose Sensor Market Forecast, CGM Transmitter Market & Forecast, CGM User and  CGM Reimbursement,  Insulin Pen (Disposable Insulin Pen, Reusable Insulin Pen, Smart Insulin Pen, Insulin Pen Needle Market ,Insulin Pen Users and Reimbursement Policies), Insulin Pump (Insulin Pump Market, Insulin Pump Users, Insulin Pump Products and Reimbursement Policies), Company Analysis (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (B.D.), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)’’ provides a detailed analysis of Diabetes Market in the United States.


    united-states-diabetes-market-share


    Segments Market based on Devices

    1.    Continuous Glucose Monitoring (CGM)
    2.    Self-Monitoring Blood Glucose (SMBG)
    3.    Insulin Pen
    4.    Insulin Pump


    United States Diabetes Sub-Segment Analysis

    1. Continuous Glucose Monitoring (CGM) – United State Food Market breakup from four viewpoints

    1.    Glucose Sensor Market & Forecast
    2.    CGM Transmitter Market & Forecast
    3.    CGM User
    4.    CGM Reimbursement


    2. SMBG – United State Food Market breakup from five viewpoints

    1.    Test Strips Market and Forecast
    2.    Lancet Market and Forecast
    3.    Meter Market and Forecast
    4.    Blood Glucose (SMBG) Users
    5.    Blood Glucose Devices Reimbursement


    3. Insulin Pen Market – United State Food Market breakup from six viewpoints

    1.    Disposable Insulin Pen
    2.    Reusable Insulin Pen
    3.    Smart Insulin Pen
    4.    Insulin Pen Needle Market
    5.    Insulin Pen Users
    6.    Reimbursement Policies


    4. Insulin Pump Market – United State Food Market breakup from four viewpoints

    1.    Insulin Pump Market
    2.    Insulin Pump Users
    3.    Insulin Pump Products
    4.    Reimbursement Policies


    All the 13 Companies Studied in the Report have been Studied from 3 Points

    •    Company Overview
    •    Recent Developments
    •    Financial Insight


    Company Analysis

    1.    B. Braun Melsungen AG
    2.    Eli Lilly and Company
    3.    Terumo Corporation
    4.    Becton, Dickinson (B.D.)
    5.    Novo Nordisk
    6.    Ypsomed AG
    7.    Medtronic
    8.    Insulet Corporations
    9.    Abbott Laboratories
    10.    DarioHealth Crop
    11.    Dexcom, Inc
    12.    Roche Diagnostic
    13.    Tandem Diabetes Care


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2017 - 2022
    Forecast Period 2023 - 2028
    Market US$ Billion
    Segment Covered CGM, SMBG, Insulin Pen, and Insulin Pump
    Companies Covered B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (B.D.), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)


    Key Benefits of the Report

    • This report provides current market estimates and forecasts for United States Diabetic Market.
    • Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
    • Detailed analysis of United States SMBG Market.
    • Detailed analysis of United States CGM Market.
    • Detailed analysis of United States Insulin Pump Market.
    • Detailed analysis of United States Insulin Pen Market.
    • United States Diabetic Market – Growth Drivers and Challenges.
    • Key sustainability strategies adopted by market players.

    1.    Introduction

    2.    Research & Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    United States Diabetes Market

    6.    United States Diabetes Population & Forecast

    6.1    Type 1 Diabetes
    6.2    Type 2 Diabetes


    7.    Market Share – United States Diabetes Analysis

    7.1    By Types


    8.    Continuous Glucose Monitoring Market (CGM) – Market & Users

    8.1    CGM Market by Components

    8.1.1    Glucose Sensor Market
    8.1.2    CGM Transmitter Market

    8.2    CGM User
    8.3    Reimbursement Policies of CGM Devices in United States


    9.    Blood Glucose Device (SMBG) – United States Market & Users

    9.1    Market

    9.1.1    Type 1 (SMBG)
    9.1.2    Type 2 (SMBG)

    9.2    Test Strips Market

    9.2.1    Type 1 
    9.2.2    Type 2 

    9.3    Lancet Market and Forecast

    9.3.1    Type 1
    9.3.2    Type 2

    9.4    Meter Market and Forecast

    9.4.1    Type 1
    9.4.2    Type 2

    9.5    Blood Glucose (SMBG) Users

    9.5.1    Type 1
    9.5.2    Type 2

    9.6    Reimbursement Policies of Blood Glucose Devices in United States


    10.    Insulin Pen – United States Market & User

    10.1    Insulin Pen Market

    10.1.1    Disposable Insulin Pen
    10.1.2    Reusable Insulin Pen
    10.1.3    Smart Insulin Pen

    10.2    Insulin Pen User

    10.2.1    Disposable Insulin Pen
    10.2.2    Reusable Insulin Pen
    10.2.3    Smart Insulin Pen

    10.3    Insulin Pen Needle Market

    10.4    Reimbursement Policies of Insulin Pen in United States

    11.    Insulin Pump - United States Market & Users

    11.1    Insulin Pump Market

    11.1.1    Type 1
    11.1.2    Type 2

    11.2    Insulin Pump User

    11.2.1    Type 1
    11.2.2    Type 2

    11.3    Differentiation Points of Insulin Pump Products in United States

    11.3.1    Animas Vibe
    11.3.2    Medtronic 530G with Enlite
    11.3.3    Insulet OmniPod
    11.3.4    Tandem t: slim 
    11.3.5    Roche Accu-Chek Combo

    11.4    Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

    11.4.1    Medtronic

    11.5    Insulet Corporation

    11.5.1    Training Structure for New Patients - Insulet Corporation

    11.6    Animas Corporation

    11.6.1    Training Modules for New Patients
    11.6.2    Training Modules for HCP (Health Care Professional)

    11.7     Tandem Diabetes Care

    11.8    Reimbursement Policies on Insulin Pump


    12.    Insulin Pen – Company Analysis

    12.1    B. Braun Melsungen AG

    12.1.1    Overview
    12.1.2    Recent Development
    12.1.3    Revenue

    12.2    Eli Lilly

    12.2.1    Overview
    12.2.2    Recent Development
    12.2.3    Revenue

    12.3    Terumo Corporation

    12.3.1    Overview
    12.3.2    Recent Development
    12.3.3    Revenue

    12.4    BD

    12.4.1    Overview
    12.4.2    Recent Development
    12.4.3    Revenue

    12.5    Novo Nordisk A/S

    12.5.1    Overview
    12.5.2    Recent Development
    12.5.3    Revenue

    12.6    Ypsomed AG

    12.6.1    Overview
    12.6.2    Recent Development
    12.6.3    Revenue


    13.    Insulin Pump – Company Analysis

    13.1    Medtronic

    13.1.1    Overview
    13.1.2    Recent Development
    13.1.3    Revenue

    13.2    Insulet Corporation

    13.2.1    Overview
    13.2.2    Recent Development
    13.2.3    Revenue


    14.    SMBG – Company Analysis

    14.1    DarioHealth Corp

    14.1.1    Overview
    14.1.2    Recent Development
    14.1.3    Revenue

    14.2    Abbott Laboratories

    14.2.1    Overview
    14.2.2    Recent Development
    14.2.3    Revenue


    15.    CGM – Company Analysis

    15.1    Dexcom Inc

    15.1.1    Overview 
    15.1.2    Recent Development
    15.1.3    Revenue

    15.2    Roche

    15.2.1    Overview
    15.2.2    Recent Development
    15.2.3    Revenue

    15.3    Tandem Diabetes Care

    15.3.1    Overview
    15.3.2    Recent Development
    15.3.3    Revenue


    List of Figures:

    Figure-01:    United States – Diabetes Market (Billion US$), 2017 – 2022
    Figure-02:    United States – Forecast for Diabetes Market (Billion US$), 2023 – 2028
    Figure-03:    United States – Type 1 Diabetes Population (Thousand), 2017 – 2022
    Figure-04:    United States – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
    Figure-05:    United States – Type 2 Diabetes Population (Thousand), 2017 – 2022
    Figure-06:    United States – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
    Figure-07:    United States – Glucose Sensor Market Market (Million US$), 2017 – 2023
    Figure-08:    United States – Forecast for Glucose Sensor Market Market (Million US$), 2023 – 2028
    Figure-09:    United States – CGM Transmitter Market Market (Million US$), 2017 – 2023
    Figure-10:    United States – Forecast for CGM Transmitter Market Market (Million US$), 2023 – 2028
    Figure-11:    United States – CGM User (Thousand), 2017 – 2023
    Figure-12:    United States – Forecast for CGM User (Thousand),2023 – 2028
    Figure-13:    United States – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-14:    United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-15:    United States – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-16:    United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-17:    United States – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-18:    United States – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-19:    United States – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-20:    United States – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-21:    United States – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-22:    United States – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-23:    United States – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-24:    United States – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-25:    United States – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-26:    United States – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-27:    United States – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-28:    United States – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-29:    United States – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
    Figure-30:    United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
    Figure-31:    United States – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
    Figure-32:    United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
    Figure-33:    United States – Disposable Insulin Pen Market (Million US$), 2017 – 2023
    Figure-34:    United States – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
    Figure-35:    United States – Reusable Insulin Pen Market (Million US$), 2017 – 2023
    Figure-36:    United States – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
    Figure-37:    United States – Smart Insulin Pen Market (Million US$), 2017 – 2023
    Figure-38:    United States – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
    Figure-39:    United States – Disposable Insulin Pen User (Thousand), 2017 – 2022
    Figure-40:    United States – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
    Figure-41:    United States – Reusable Insulin Pen User (Thousand), 2017 – 2022
    Figure-42:    United States – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
    Figure-43:    United States – Smart Insulin Pen User (Thousand), 2017 – 2022
    Figure-44:    United States – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
    Figure-45:    United States – Insulin Pen Needle Market Market (Million US$), 2017 – 2023
    Figure-46:    United States – Forecast for Pen Needle Market for Market (Million US$), 2023 – 2028
    Figure-47:    United States – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-48:    United States – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-49:    United States – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-50:    United States – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-51:    United States – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
    Figure-52:    United States – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
    Figure-53:    United States – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
    Figure-54:    United States – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
    Figure-55:    B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
    Figure-56:    B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-57:    Eli Lilly – Global Revenue (Million US$), 2017 – 2022
    Figure-58:    Eli Lilly – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-59:    Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
    Figure-60:    Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-61:    BD – Global Revenue (Billion US$), 2017 – 2022
    Figure-62:    BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-63:    Novo Nordisk A/S – Global Revenue (Million US$), 2017 – 2022
    Figure-64:    Novo Nordisk A/S – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-65:    Ypsomed AG – Global Revenue (Million US$), 2017 – 2022
    Figure-66:    Ypsomed AG – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-67:    Medtronic – Global Revenue (Billion US$), 2017 – 2022
    Figure-68:    Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-69:    Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
    Figure-70:    Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-71:    DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
    Figure-72:    DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-73:    Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
    Figure-74:    Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-75:    Dexcom Inc – Global Revenue (Million US$), 2017 – 2022
    Figure-76:    Dexcom Inc – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-77:    Roche – Global Revenue (Billion US$), 2017 – 2022
    Figure-78:    Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-79:    Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
    Figure-80:    Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028


    List of Tables:

    Table-01:    United States – Diabetes Market Share by Type (Percent), 2017 – 2022
    Table-02:    United States – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028

    • Description
      Price
    • Chapter 1, 4 & 5     Pages : 8
      $300
    • Chapter 6     Pages : 4
      $400
    • Chapter 8     Pages : 8
      $500
    • Chapter 9.1     Pages : 4
      $300
    • Chapter 9.2     Pages : 4
      $300
    • Chapter 9.3     Pages : 4
      $300
    • Chapter 9.4     Pages : 4
      $300
    • Chapter 9.5 & 9.6     Pages : 5
      $300
    • Chapter 10.1     Pages : 6
      $300
    • Chapter 10.2     Pages : 6
      $300
    • Chapter 10.3 & 10.4     Pages : 4
      $300
    • Chapter 11.1     Pages : 4
      $300
    • Chapter 11.2     Pages : 4
      $300
    • Chapter 11.3     Pages : 5
      $300
    • Chapter 11.4, 11.5, 11.6, 11.7 & 11.8     Pages : 7
      $300
    • Chapter 12.1     Pages : 5
      $150
    • Chapter 12.2     Pages : 5
      $150
    • Chapter 12.3     Pages : 5
      $150
    • Chapter 12.4     Pages : 5
      $0
    • Chapter 12.5     Pages : 5
      $150
    • Chapter 12.6     Pages : 5
      $150
    • Chapter 13.1     Pages : 5
      $150
    • Chapter 13.2     Pages : 5
      $150
    • Chapter 14.1     Pages : 5
      $150
    • Chapter 14.2     Pages : 5
      $150
    • Chapter 15.1     Pages : 5
      $150
    • Chapter 15.2     Pages : 5
      $150
    • Chapter 15.3     Pages : 5
      $150

    Related Reports